Céline Moret
Scientific collaborator, biomedical ethics group, iEH2 - Institut Éthique Histoire Humanités, Université de Genève 1
Studies informed consent in high-throughput sequencing and scientific validity of direct-to-consumer genetic tests. 1
Key works
-
Céline Moret et al.. 2017. “ Defining categories of actionability for secondary findings in next-generation sequencing (opens in a new tab) ” . 3
The article sorts unexpected genomic findings by the kinds of action they allow, giving clinicians a more precise basis for deciding which results to discuss with patients.
Across Poet Doctor
Programs on philosophy & ethics
- Brocher Foundation
- Department of History and Philosophy of Science · University of Cambridge
- Institut für Geschichte der Medizin und Ethik in der Medizin · Charité – Universitätsmedizin Berlin
- Browse all programs on this theme
Programs on interdisciplinary health humanities
- Medical and Health Humanities Africa
- Institut des humanités en médecine · Université de Lausanne & Centre hospitalier universitaire vaudois
- Wellcome · Wellcome Trust
- Browse all programs on this theme
Positions and training
| Position | Organization |
|---|---|
| Scientific collaborator, biomedical ethics group | iEH2 - Institut Éthique Histoire Humanités 1 |
Notes
- Céline Moret, Université de Genève staff page (opens in a new tab) .
- iEH2 - Institut Éthique Histoire Humanités, official page (opens in a new tab) .
- “Defining categories of actionability for secondary findings in next-generation sequencing.” DOI record (opens in a new tab) .
- “Conversations with kidney vendors in Pakistan: an ethnographic study.” DOI record (opens in a new tab) .
- “Historia de la terapéutica en México. Recursos, tratamientos y procedimientos.” libros.facmed.unam.mx (opens in a new tab) .
- “Rethinking Conscientious Objection in Health Care.” academic.oup.com (opens in a new tab) .